Cybin, Inc. (HELP)
12.37
-1.65
(-11.77%)
USD |
NASDAQ |
Sep 18, 16:00
12.59
+0.22
(+1.78%)
Pre-Market: 08:25
Cybin Total Liabilities (Quarterly) : 17.57M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 17.57M |
| March 31, 2026 | 19.38M |
| December 31, 2025 | 16.18M |
| September 30, 2025 | 42.25M |
| June 30, 2025 | 59.05M |
| March 31, 2025 | 14.88M |
| December 31, 2024 | 9.252M |
| September 30, 2024 | 5.458M |
| June 30, 2024 | 3.519M |
| March 31, 2024 | 7.460M |
| December 31, 2023 | 6.448M |
| September 30, 2023 | 6.836M |
| June 30, 2023 | 4.534M |
| March 31, 2023 | 4.184M |
| December 31, 2022 | 3.224M |
| September 30, 2022 | 3.553M |
| June 30, 2022 | 4.965M |
| Date | Value |
|---|---|
| March 31, 2022 | 6.331M |
| December 31, 2021 | 4.802M |
| September 30, 2021 | 4.792M |
| June 30, 2021 | 5.304M |
| March 31, 2021 | 4.769M |
| December 31, 2020 | 6.577M |
| January 31, 2020 | |
| October 31, 2019 | |
| July 31, 2019 | 0.0104M |
| April 30, 2019 | 0.0114M |
| January 31, 2019 | 0.0068M |
| October 31, 2018 | 0.0127M |
| July 31, 2018 | 0.0122M |
| April 30, 2018 | 0.0006M |
| January 31, 2018 | 0.0011M |
| October 31, 2017 | 0.0124M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Atai Beckley, Inc. | 88.36M |
| Clearmind Medicine, Inc. | 3.961M |
| InMed Pharmaceuticals, Inc. | 1.955M |
| NervGen Pharma Corp. | 51.39M |
| Milestone Pharmaceuticals, Inc. | 163.41M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 259.66M |
| Shareholders Equity (Quarterly) | 242.09M |
| Current Ratio | 10.97 |